Keynote Speakers
Susan Wyllie, PhD
Affiliation: School of Life Sciences, University of Dundee, Dundee (United Kingdom)
Dario S. Zamboni, PhD
Affiliation: University of São Paulo (Brazil)
Lars Gille, PhD
Affiliation: Department of Biomedical Sciences, University of Veterinary Medicine Vienna (Austria)
Title: Antileishmanial Activity of Synthetic Anthracene Endoperoxides: Efficiency and Mechanism.
Claudia M. d’Avila, PhD
Affiliation: Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro (Brazil)
Title: Monoxenous trypanosomatids in vertebrate hosts: facts or artifacts?
Hira Nakhasi, PhD
Affiliation: Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Research and Review, US Food and Drug Administration, Silver Spring (USA)
Title: Second generation leishmanization: using genetically modified dermotropic Leishmania as a pan Leishmania vaccine.
Gaetano Oliva, PhD
Affiliation: University of Naples Federico II (Italy)
Title: Canine leishmaniosis: preventative and therapeutic strategies to limit the dogs infectiousness.
Fabienne Tacchini-Cottier, PhD
Affiliation: University of Lausanne (Switzerland)
Title: The importance of neutrophils in cutaneous leishmaniasis.
Reuven Bergman, PhD
Affiliation: Rambam Health Care Campus (Israel)
Sergi Segarra, PhD
Affiliation: R&D Bioiberica SAU (Spain)
Title: Immunomodulation with dietary nucleotides in companion animals to optimize global prevention, treatment, and control strategies for leishmaniasis.
Vyacheslav Yurchenko, PhD
Affiliation: University of Ostrava (Czech Republic)
Title: Catalase is detrimental for Leishmania mexicana development and virulence.
XXX, PhD
Affiliation: